west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "WU Xiaohui" 3 results
  • Assessment of the Efficacy of Glucosamine Hydrochloride Combined with Diacerein in the Treatment of Knee Osteoarthritis with Bone Marrow Edema

    目的 研究盐酸氨基葡萄糖联合双醋瑞因在伴有骨髓水肿(BME)的膝骨关节炎(KOA)中的疗效评估。 方法 依据MRI检查结果,选取2011年1月-2012年6月入院60例伴BME的KOA患者随机分入A组(口服盐酸氨基葡萄糖)、B组(口服双醋瑞因)、C组(口服盐酸氨基葡萄糖和双醋瑞因),每组各20例;另纳入同期30例不伴BME的KOA患者30例为D组(口服盐酸氨基葡萄糖和双醋瑞因)。完成标准方案后24周,随访临床疗效和影像学评分及炎症因子变化。 结果 治疗24周后4组在20 m 步行后视觉模拟评分(VAS)、关节压痛VAS评分较治疗前有改善(P<0.05);在BME改善方面,C组容积积分和程度积分均优于A、B两组(P<0.05);在炎症因子方面,治疗24周后4组白细胞介素(IL)-1β、IL-6和肿瘤坏死因子α表达水平明显降低(P<0.05)。 结论 盐酸氨基葡萄糖联合双醋瑞因能有效改善伴有BME的KOA患者临床症状、降低炎症因子表达水平以及促进BME在影像学方面的改善。

    Release date: Export PDF Favorites Scan
  • Study on the correlation of elderly knee osteoarthritis with bone marrow edema and osteoprotegerin, dickkopf-1, sclerostin

    Objective To investigate the correlation of elderly knee osteoarthritis with bone marrow edema and osteoprotegerin, DKK-1 (dickkopf-1), sclerostin. Methods A total of 100 elderly patients with knee osteoarthritis in Sichuan Province Orthopedic Hospital from September 2017 to December 2018 were selected and divided into bone marrow edema group (50 cases) and non-bone marrow edema group (50 cases). The patients’ basic data, Western Ontario and McMaster University Osteoarthritis Index (WOMAC) scores and Visual Analogue Scale scores were collected. The patients’ serum osteoprotegerin, DKK-1, sclerostin, C-reactive protein, and erythrocyte sedimentation rate were tested, and the differences between the two groups were compared. The correlation of the detection indicators and bone marrow edema and its clinical indicators was explored. Results There was no significant difference in age, gender, course of disease, C-reactive protein and erythrocyte sedimentation rate between the two groups (P>0.05). WOMAC scores (76.1±5.4 vs. 67.5±6.6), Visual Analogue Scale scores (8.4±1.1 vs. 5.5±0.9), proportion of synovitis (84.0% vs. 52.0%), osteoprotegerin [(1.3±1.1) vs. (0.6±0.5) μg/L], DKK-1 [(18.4±16.9) vs. (6.9±6.0) μg/L] and sclerostin [(147.3±119.4) vs. (99.7±70.7) pg/mL] in the bone marrow edema group were higher than those in the non-bone marrow edema group (P<0.05). There was no statistically significant correlation of the bone marrow edema volume score and degree score and serum osteoprotegerin of patients in the bone marrow edema group (P>0.05). The bone marrow edema volume score and degree score of patients in the bone marrow edema group were positively correlated with serum DKK-1 (volume score rs=0.464, P=0.001; degree score rs=0.379, P=0.007) and sclerostin (volume score rs=0.316, P=0.025; degree score rs=0.461, P=0.003). Conclusion In elderly patients with knee osteoarthritis and bone marrow edema, the local bone metabolism indicators of osteoprotegerin, DKK-1 and sclerostin are up-regulated, especially DKK-1 and sclerostin are related to the severity of bone marrow edema.

    Release date: Export PDF Favorites Scan
  • Comparison of the Efficacy of Glucosamine Hydrochloride Combined with Anti-bone Hyperplasia Tablets in the Treatment of Different Types of Knee Osteoarthritis

    目的 研究盐酸氨基葡萄糖联合抗骨增生片治疗膝骨关节炎(KOA)的可行性及安全性。 方法 2011年1月-2012年8月选取90例KOA患者,按关节面改变部位归入A组(髌股关节面改变)、B组(胫股关节面改变)、C组(全关节软骨改变),每组30例。均予以盐酸氨基葡萄糖、抗骨增生片治疗,12周后观察治疗前后临床疗效、综合疗效及安全性等指标及评分。 结果 ① 3组比较,A组疗效高于B、C组(P<0.05);② A组与B、C两组在平地行走20 m疼痛评分、关节压痛度评分和骨关节炎指数(WOMAC)评分方面差异有统计学意义(P<0.05);③ A组和B、C两组在患者自我疗效评价、医生疗效评价方面差异有统计学意义(P<0.05);④ A组在治疗12周后血液血沉、C反应蛋白(CRP)、白细胞介素(IL)-1、IL-6、肿瘤坏死因子-α(TNF-α)较治疗前差异有统计表学意义(P<0.05);B组则在CRP、IL-6、TNF-α较治疗前有差异(P<0.05);C组仅在CRP、TNF-α较前有差异(P<0.05);⑤3组不良反应发生率则无明显差异(P>0.05)。 结论 盐酸氨基葡萄糖联合抗骨增生片治疗髌股关节面改变的KOA疗效优于胫股关节改变,且治疗方案可行、安全、优效。

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content